A case of Takotsubo cardiomyopathy with cardiogenic shock after influenza infection successfully recovered by IMPELLA support

Nakagaito, Masaki; Hori, Masakazu; Ueno, Hiroshi; Kinugawa, Koichiro

doi:10.1007/s10047-019-01112-8

Cited by 12 publications

(8 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Several reports have shown Takotsubo cardiomyopathy in COVID-19 patients (180)(181)(182)(183)(184)(185). Correspondingly, this condition is also reported in influenza-infected patients (186)(187)(188)(189). These reports suggest that cardiomyopathy, especially stress-induced cardiomyopathy is reported in influenza viral infected and COVID-19 patients.…”

Section: Comparison Of Cardiovascular Conditions Associated With Sarsmentioning

confidence: 72%

Immune Mechanisms in Cardiovascular Diseases Associated With Viral Infection

2020

View full text Add to dashboard Cite

Influenza virus infection causes 3-5 million cases of severe illness and 250,000-500,000 deaths worldwide annually. Although pneumonia is the most common complication associated with influenza, there are several reports demonstrating increased risk for cardiovascular diseases. Several clinical case reports, as well as both prospective and retrospective studies, have shown that influenza can trigger cardiovascular events including myocardial infarction (MI), myocarditis, ventricular arrhythmia, and heart failure. A recent study has demonstrated that influenza-infected patients are at highest risk of having MI during the first seven days of diagnosis. Influenza virus infection induces a variety of pro-inflammatory cytokines and chemokines and recruitment of immune cells as part of the host immune response. Understanding the cellular and molecular mechanisms involved in influenza-associated cardiovascular diseases will help to improve treatment plans. This review discusses the direct and indirect effects of influenza virus infection on triggering cardiovascular events. Further, we discussed the similarities and differences in epidemiological and pathogenic mechanisms involved in cardiovascular events associated with coronavirus disease 2019 (COVID-19) compared to influenza infection.

show abstract

Section: Comparison Of Cardiovascular Conditions Associated With Sarsmentioning

confidence: 72%

Immune Mechanisms in Cardiovascular Diseases Associated With Viral Infection

2020

View full text Add to dashboard Cite

show abstract

“…TTS has been previously reported in infectious diseases, mainly in bacterial sepsis, and rarely in the setting of viral infections (47,48). The influenza virus is one of the most recognized viruses to cause TTS during the acute infection or following vaccination (49)(50)(51)(52)(53)(54)(55)(56). However, the incidence of TTS in the setting of influenza or other viral infections is not known since no studies have been dedicated to investigate the echocardiographic findings in the affected patients.…”

Section: Epidemiology and Presentationmentioning

confidence: 99%

Takotsubo Syndrome During the COVID-19 Pandemic: State-of-the-Art Review

Moady¹,

Atar²

2021

CJC Open

View full text Add to dashboard Cite

show abstract

“…The clinical presentations may often be difficult to distinguish from acute coronary syndrome (ACS) presenting with chest pain, dyspnea, pulmonary edema, ischemic changes on ECG or elevated troponin, and rarely presents in cardiogenic shock requiring circulatory support [4]. Only a limited number of case reports have reported the use of Impella device in patients with SIC in cardiogenic shock, with varying triggers including emotional stress [9], elective surgery [3], chemotherapy [10], or an influenza infection [11].…”

Section: Discussionmentioning

confidence: 99%